Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Demonstration of Reverse Remodeling Effects of Entresto (Valsartan/Sacubitril) Using Echocardiography Endocardial Surface Analysis

Condition:   Heart Failure
Intervention:   Drug: Entresto
Sponsor:   University of Chicago
Recruiting - verified April 2016

Pilot - Peri-operative Beta Blockade

Conditions:   Adrenergic Beta-Receptor Blockader;   Troponin Levels;   Cardiomyopathy, Post-surgical
Intervention:   Drug: metoprolol
Sponsor:   Washington University School of Medicine
Recruiting - verified April 2016

Effect of His-Ventricular (HV) Interval Optimisation in Cardiac Resynchronisation Therapy

Condition:   Heart Failure
Intervention:   Other: His-Ventricular (HV) optimisation
Sponsor:   Hull and East Yorkshire Hospitals NHS Trust
Not yet recruiting - verified April 2016

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

Conditions:   Duchenne Muscular Dystrophy;   Cardiomyopathy
Intervention:   Drug: Allogeneic Cardiosphere-Derived Cells (CAP-1002)
Sponsor:   Capricor Inc.
Recruiting - verified April 2016

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients

Conditions:   Heart Failure;   Cardiomyopathy;   Ventricular Dysfunction
Interventions:   Biological: MPC Intramyocardial Injection;   Drug: Control Solution
Sponsors:   Annetine Gelijns;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2016

Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology

Conditions:   Syndrome X;   Takotsubo Cardiomyopathy
Intervention:   Other: BaroReflex Sensitivity, endothelial function measurement
Sponsor:   Ospedale San Giovanni Bellinzona
Completed - verified April 2016

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease

Condition:   BRAF V600E Mutation
Interventions:   Drug: Dabrafenib Mesylate;   Drug: Trametinib Dimethyl Sulfoxide
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified September 2015

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Condition:   LMNA-Related Dilated Cardiomyopathy
Intervention:   Drug: ARRY-371797, p38 inhibitor; oral
Sponsor:   Array BioPharma
Active, not recruiting - verified April 2016

Resveratrol: a Potential Anti-remodeling Agent in Heart Failure, From Bench to Bedside

Condition:   Non-ischemic Cardiomyopathy
Interventions:   Other: Resveratrol;   Other: Placebo
Sponsors:   St. Boniface General Hospital Research Centre;   Canadian Centre for Agri-Food Research in Health and Medicine;   Agriculture and Agri-Food Canada;   Manitoba Medical Service Foundation
Recruiting - verified April 2016

Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients - TRICHAMPION STUDY

Condition:   Hypertrophic Cardiomyopathy With Obstruction
Intervention:   Device: CRT-P Implant
Sponsor:   St. Jude Medical
Recruiting - verified April 2016

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Conditions:   Transthyretin Mutations;   Transthyretin Amyloidosis
Intervention:   Other: None. Observational Study.
Sponsor:   Pfizer
Recruiting - verified April 2016